VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CASI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CASICASI Pharmaceuticals, Inc.
$0.15$2M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCASIQuarterly Financials

CASI Pharmaceuticals, Inc. (CASI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

CASI Pharmaceuticals, Inc. (CASI) quarterly income statement — complete revenue, gross profit & net income history

CASI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20
Sales/Revenue3.08M4.17M6.24M13.36M7.79M3.98M3.41M6.87M8.84M9.82M8.35M15.26M10.21M8.57M9.06M9.16M8.11M7.16M5.74M4.82M
Revenue Growth %-60.54%4.93%83.04%94.3%-11.82%-59.48%-59.16%-54.95%-13.46%14.55%-7.89%66.62%25.9%19.7%57.98%89.92%91.23%168.14%68.41%258.78%
Cost of Goods Sold2.37M2.12M2.62M10.13M3.75M1.91M1.6M2.81M3.65M3.99M3.38M4.27M4.25M3.55M3.76M3.8M3.42M2.98M2.36M1.95M
COGS % of Revenue77.04%50.71%42%75.83%48.09%48.05%47.02%40.95%41.28%40.59%40.47%28%41.58%41.41%41.47%41.49%42.12%41.64%41.11%40.48%
Gross Profit706K2.06M3.62M3.23M4.04M2.07M1.81M4.06M5.19M5.83M4.97M10.99M5.97M5.02M5.3M5.36M4.7M4.18M3.38M2.87M
Gross Margin %22.96%49.29%58%24.17%51.91%51.95%52.98%59.05%58.72%59.41%59.53%72%58.42%58.59%58.53%58.51%57.88%58.36%58.89%59.52%
Gross Profit Growth %-82.55%-0.44%100.39%-20.47%-22.06%-64.57%-63.65%-63.06%-13.01%16.15%-6.32%105.06%27.07%20.17%57.02%86.69%94.49%2614.29%1632.31%4935.09%
Operating Expenses11.38M13.18M14M16.14M12.51M10.86M11.03M8.79M10.29M13.87M12.18M23.63M11.68M11.41M12.26M16.41M11.59M12.16M18.98M18.08M
OpEx % of Revenue370.18%315.76%224.33%120.86%160.52%272.83%323.41%127.9%116.37%141.27%145.94%154.85%114.39%133.14%135.3%179.15%142.84%169.76%330.81%374.91%
Selling, General & Admin9.54M11.04M11.92M11.92M10.61M10.37M8.55M11.57M8.04M12.52M9.71M11.84M8.41M8.92M8.6M12.65M8.69M8.85M8.22M9.11M
SG&A % of Revenue310.15%264.53%191.04%89.23%136.14%260.54%250.78%168.32%90.96%127.51%116.29%77.59%82.39%104.02%94.92%138.12%107.15%123.54%143.25%188.86%
Research & Development1.41M1.72M1.94M3.67M1.52M1.25M2.48M2.31M2.4M2.61M2.53M4.25M3.9M3.85M3.99M4.01M2.9M2.25M5.26M9.67M
R&D % of Revenue45.95%41.29%31.03%27.45%19.52%31.52%72.63%33.66%27.14%26.62%30.36%27.84%38.24%44.92%44.05%43.83%35.69%31.49%91.67%200.6%
Other Operating Expenses433K415K141K558K379K-765K0-1000K-153K-1000K-59K1000K-637K-1000K-333K-256K01000K1000K-702K
Operating Income-10.68M-11.13M-10.38M-12.91M-8.46M-8.79M-9.22M-4.73M-5.09M-8.04M-7.21M-12.64M-5.72M-6.39M-6.96M-11.05M-6.89M-7.98M-15.6M-15.21M
Operating Margin %-347.22%-266.47%-166.33%-96.69%-108.61%-220.88%-270.43%-68.85%-57.65%-81.86%-86.41%-82.85%-55.98%-74.55%-76.77%-120.65%-84.96%-111.39%-271.91%-315.39%
Operating Income Growth %-26.15%-26.58%-12.58%-172.85%-66.12%-9.33%-27.81%62.56%10.88%-25.79%-3.68%-14.42%17.05%19.89%55.4%27.35%63.07%10.23%-77.82%-24.85%
EBITDA-10.09M-10.96M-10.55M-12.33M-7.53M-7.85M-8.28M-3.8M-4.49M-7.43M-6.61M-11.75M-4.95M-6.06M-6.52M-10.64M-6.47M-7.51M-15.08M-14.73M
EBITDA Margin %-328.27%-262.44%-169.12%-92.33%-96.61%-197.38%-243%-55.25%-50.8%-75.7%-79.16%-77.02%-48.49%-70.65%-71.99%-116.14%-79.77%-104.9%-262.92%-305.54%
EBITDA Growth %-34.08%-39.51%-27.39%-224.7%-67.7%-5.65%-25.37%67.68%9.34%-22.73%-1.28%-10.49%23.47%19.38%56.74%27.81%64.47%10.25%-82.84%-25.16%
D&A (Non-Cash Add-back)582.75K00582.75K935.25K935.25K935.25K935.25K605.5K605.5K605.5K890K765K334K433K413K421K465K516K475K
EBIT-10.69M-10.96M-10.55M-10.34M-8.09M-9.55M-9.22M-4.76M-5.25M-8M-7.27M-5.1M-6.35M-7.75M-7.29M-11.3M-6.89M-6.92M-10.1M-10.03M
Net Interest Income-185K-199K-120K0-61K-55K-61K112K161K139K202K26K-13K40K74K60K79K76K106K91K
Interest Income10K45K77K000131K112K161K139K202K26K040K74K60K79K76K106K91K
Interest Expense195K244K197K061K55K192K0000013K0000000
Other Income/Expense-206K-76K-371K-1.46M1.19M1.82M-309K-1.16M629K-2.11M1.38M-4.72M694K-1.1M-1.44M5.65M-3.13M1.23M1.91M1.18M
Pretax Income-10.88M-11.2M-10.75M-14.37M-7.28M-6.96M-9.53M-5.89M-4.47M-10.15M-5.83M-17.36M-5.02M-7.49M-8.4M-5.39M-10.02M-6.74M-13.68M-14.02M
Pretax Margin %-353.92%-268.29%-172.28%-107.59%-93.4%-175.04%-279.5%-85.73%-50.53%-103.36%-69.86%-113.78%-49.18%-87.4%-92.69%-58.91%-123.51%-94.16%-238.56%-290.83%
Income Tax02.17M001.12M00-1K0-80K01.98M00000000
Effective Tax Rate %0%-19.41%0%0%-15.33%0%0%0.02%0%0.79%0%-11.4%0%0%0%0%0%0%0%0%
Net Income-10.88M-13.38M-10.75M-14.37M-8.39M-6.96M-9.53M-6.05M-4.63M-10.24M-6.01M-19.54M-5.2M-7.68M-8.6M-5.6M-10.22M-6.95M-13.88M-14.2M
Net Margin %-353.92%-320.36%-172.28%-107.59%-107.72%-175.04%-279.5%-88.09%-52.44%-104.27%-71.99%-128.04%-50.93%-89.58%-94.86%-61.16%-126.04%-96.98%-242.03%-294.46%
Net Income Growth %-29.64%-92.03%-12.83%-137.32%-81.12%31.98%-58.56%69.01%10.88%-33.32%30.1%-248.81%49.13%-10.57%38.08%60.55%39.69%20.11%-64.47%-10.08%
Net Income (Continuing)-10.88M-13.38M-10.75M-14.37M-8.39M-6.96M-9.53M-5.89M-4.47M-10.07M-5.83M-19.34M-5.02M-7.49M-8.4M-5.39M-10.02M-6.74M-13.68M-14.02M
Discontinued Operations00000000000000000000
Minority Interest0000000021.64M21.62M22.64M22.36M21.5M22.66M23.73M23.46M22.91M22.7M22.16M22.03M
EPS (Diluted)-0.68-0.86-0.69-0.93-0.55-0.52-0.71-0.45-0.35-0.77-0.45-1.45-0.38-0.56-0.62-0.41-0.73-0.50-1.11-1.21
EPS Growth %-23.64%-65.38%2.82%-106.67%-57.14%32.47%-57.78%68.97%7.89%-37.5%27.42%-253.66%47.95%-12%44.14%66.12%49.31%41.86%-30.59%9.7%
EPS (Basic)-0.68-0.86-0.69-0.93-0.55-0.52-0.71-0.45-0.35-0.77-0.45-1.45-0.38-0.56-0.62-0.41-0.73-0.50-1.11-1.21
Diluted Shares Outstanding16.05M15.51M15.49M15.49M15.29M13.52M13.38M13.38M13.38M13.34M13.34M13.46M13.61M13.61M13.8M13.8M13.98M13.98M12.48M11.76M
Basic Shares Outstanding16.05M15.51M15.49M15.49M15.29M13.52M13.38M13.38M13.38M13.34M13.34M13.46M13.61M13.61M13.8M13.8M13.98M13.89M12.48M11.76M
Dividend Payout Ratio--------------------